Gregory brings decades of leadership in molecular diagnostics, shaping industry-defining strategies at Roche and Illumina—where he served as VP of IVD Development and SVP of Diagnostics. He has also advised top healthtech innovators as a board member at numares AG and Scientific Advisory Board member at Everlywell. With deep expertise in business development, clinical assay development, and global diagnostics markets, Gregory’s vision bridges science, strategy, and real-world impact. With his help, Compass will be driving the next wave of precision diagnostics: powered by AI, built for clinical utility, and scaled for global reach.